Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Onglyza Saxagliptin hydrochloride 2.98mg equivalent to Saxagliptin 2.5mg Film coated tablet AstraZeneca Limited Bristol-Myers Squibb Company, Indiana, United States of America
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Onglyza Saxagliptin hydrochloride 5.95mg equivalent to Saxagliptin 5mg Film coated tablet AstraZeneca Limited Bristol-Myers Squibb Company, Indiana, United States of America

Dated this 31st day of July 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Issue Number